CD30-Positive Neoplastic Cells Present
3 clinical trials · Condition
◉ Watch CD30-Positive Neoplastic Cells Present
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas (NCT03373305) | City of Hope Medical Center | 2019-03-01 |
| Ceritinib With Brentuximab Vedotin in Treating Patients With ALK-Positive Anaplastic Large Cell Lymphoma (NCT02729961) | University of Washington | 2018-01-03 |
| Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery (NCT03007030) | M.D. Anderson Cancer Center | 2017-04-05 |
Track CD30-Positive Neoplastic Cells Present automatically
Every clearance here is in the API, with alerts when new ones post.